Home › Companies › Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc. (VRCA) proxy voting records

How asset managers voted at Verrica Pharmaceuticals Inc.’s shareholder meetings, one page per proxy season, compiled from the votes funds and managers report on SEC Form N-PX and the company’s own results on Form 8-K.

TickerVRCA
CUSIP issuer number92511W
SEC CIK1660334

Recent shareholder votes

June 6, 2024 annual meeting (2023-2024 proxy season): 4 items in Verrica Pharmaceuticals Inc.'s official results (Form 8-K, filed June 10, 2024); lowest support 84% of votes cast (Elect Director: Mark Prygocki). Full results and how funds voted.

Each line is the company’s own Form 8-K tally as shown on that season’s page; support is FOR as a share of votes cast.

Proxy seasons

Season	Filed as	Ballot items	Asset managers
2023-2024	VERRICA PHARMACEUTICALS INC.	5	87

Earlier seasons list this company under the name VERRICA PHARMACEUTICALS INC., as its holders filed it.

Explore Verrica Pharmaceuticals Inc. in the interactive database

The seasons are grouped by the issuer number in the company’s CUSIP, not by its name. Ticker as listed by the SEC on November 6, 2026. This page is rebuilt weekly; built November 9, 2026.